BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32853404)

  • 1. Onconephrology: The intersections between the kidney and cancer.
    Rosner MH; Jhaveri KD; McMahon BA; Perazella MA
    CA Cancer J Clin; 2021 Jan; 71(1):47-77. PubMed ID: 32853404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onconephrology: the need and the emergence of a subspecialty in nephrology.
    Abudayyeh AA; Lahoti A; Salahudeen AK
    Kidney Int; 2014 May; 85(5):1002-4. PubMed ID: 24786870
    [No Abstract]   [Full Text] [Related]  

  • 3. Onconephrology: the latest frontier in the war against kidney disease.
    Salahudeen AK; Bonventre JV
    J Am Soc Nephrol; 2013 Jan; 24(1):26-30. PubMed ID: 23138480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of the International Conference on Onco-Nephrology: an emerging field in medicine.
    Capasso A; Benigni A; Capitanio U; Danesh FR; Di Marzo V; Gesualdo L; Grandaliano G; Jaimes EA; Malyszko J; Perazella MA; Qian Q; Ronco P; Rosner MH; Trepiccione F; Viggiano D; Zoccali C; Capasso G;
    Kidney Int; 2019 Sep; 96(3):555-567. PubMed ID: 31445584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular diseases and cancer: evaluation of underlying malignancy.
    Pani A; Porta C; Cosmai L; Melis P; Floris M; Piras D; Gallieni M; Rosner M; Ponticelli C
    J Nephrol; 2016 Apr; 29(2):143-152. PubMed ID: 26498294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onconephrology: An Evolving Field.
    Abudayyeh A
    Methodist Debakey Cardiovasc J; 2019; 15(4):305-307. PubMed ID: 31988693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives From an Onconephrology Interest Group: Conference Report.
    Kitchlu A; Chan CT; Leung N; Chen S; Latcha S; Tam P
    Can J Kidney Health Dis; 2020; 7():2054358120962589. PubMed ID: 33117547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onconephrology: mitigation of renal injury in chemotherapy administration.
    Selamet U; Ahdoot RS; Salasnek R; Abdelnour L; Hanna RM
    Curr Opin Nephrol Hypertens; 2024 Mar; 33(2):257-266. PubMed ID: 38095483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onconephrology 2022: An Update.
    Bonilla M; Gudsoorkar P; Wanchoo R; Herrmann SM; Jhaveri KD
    Kidney360; 2023 Feb; 4(2):258-271. PubMed ID: 36821617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onco-nephrology: AKI in the cancer patient.
    Lam AQ; Humphreys BD
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1692-700. PubMed ID: 22879433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is It Time to Integrate Frailty Assessment in Onconephrology?
    Wu HHL; Chinnadurai R; Walker RJ; Tennankore KK
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onco-nephrology: renal toxicities of chemotherapeutic agents.
    Perazella MA
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1713-21. PubMed ID: 22879440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onconephrology: Update in Anticancer Drug-Related Nephrotoxicity.
    GarcĂ­a-Carro C; Draibe J; Soler MJ
    Nephron; 2023; 147(2):65-77. PubMed ID: 35717937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opening an onconephrology clinic: recommendations and basic requirements.
    Cosmai L; Porta C; Perazella MA; Launay-Vacher V; Rosner MH; Jhaveri KD; Floris M; Pani A; Teuma C; Szczylik CA; Gallieni M
    Nephrol Dial Transplant; 2018 Sep; 33(9):1503-1510. PubMed ID: 29982771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onconephrology abstracts and publication trends: time to collaborate.
    Thakkar J; Wanchoo R; Jhaveri KD
    Clin Kidney J; 2015 Oct; 8(5):629-31. PubMed ID: 26413292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onco-nephrology: an invitation to a new field.
    Finkel KW; Howard SC
    J Clin Oncol; 2014 Aug; 32(22):2389-90. PubMed ID: 24934791
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ten Years of Onconephrology].
    Cosmai L
    G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity associated with anticancer agents: perspective on onconephrology from nephrologists.
    Matsubara T; Yokoi H; Yamada H; Yanagita M
    Int J Clin Oncol; 2023 May; 28(5):625-636. PubMed ID: 36872414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology.
    Attieh RM; Nunez B; Copeland-Halperin RS; Jhaveri KD
    Cardiorenal Med; 2024; 14(1):281-293. PubMed ID: 38684145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onconephrology: Core Curriculum 2023.
    Yarandi N; Shirali AC
    Am J Kidney Dis; 2023 Dec; 82(6):743-761. PubMed ID: 37855786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.